No. APBAM 2026 is an exclusive in-person physical event held in Singapore. We have designed the conference to maximize face-to-face networking, collaboration, and meaningful dialogue among the 300 expected attendees. There will be no virtual participation or livestreaming options.
The conference is scheduled for 3 and 4 September 2026. It will be hosted at the One Farrer Hotel, Singapore, a premier venue located near the Novena Medical Centre hub.
This conference is designed for frontline practitioners (psychiatrists, psychologists, social workers), healthcare administrators, policymakers, and educators. It is a multidisciplinary platform for anyone committed to advancing mental health and addiction recovery.
We are proud to host internationally renowned experts, including Dr. Anna Lembke (Stanford University), Dr. Robert Rhoton (Arizona Trauma Institute), and Prof. James Ogloff (Swinburne University).
APBAM – the Asia Pacific Behavioural & Addictions Medicine Conference, is a regional professional conference dedicated to advancing the field of behavioural and addictions medicine across Asia Pacific. It brings together clinicians, researchers, policymakers, and mental health advocates to share evidence-based knowledge, promote accreditation standards, and drive meaningful progress in how behavioural health conditions are understood and treated across the region.
APBAM 2026 draws a specialised audience of psychiatrists, addiction medicine specialists, psychologists, counsellors, allied health professionals, academic researchers, and public health policymakers from across the Asia Pacific region. The conference is an authoritative forum for professionals seeking CPD-accredited learning and regional networking at the highest level.
APBAM 2026 offers flexible sponsorship options to suit different organisations and goals. These range from Supporting Partner contributions, such as technology services, equipment, or expertise to financial Conference Sponsorships and Principal Partnerships. Custom packages are also available for organisations with specific engagement objectives. Contact the APBAM team to discuss what would work best for you.
Yes. APBAM 2026 welcomes sponsorship and partnership from organisations across Asia Pacific and internationally. Whether you are headquartered in Singapore, Australia, Japan, India, the United Kingdom, or anywhere else, your support is valued and your brand will receive visibility with a pan-regional audience of mental health and addictions medicine professionals.
Sponsorship and partnership slots are limited and allocated on a first-confirmed basis. Early applications are encouraged to ensure your preferred tier and any associated benefits, such as exhibition spaces and speaking slots – can be reserved. Please reach out to the APBAM organising team as soon as possible to secure your place.
To begin a conversation about sponsoring APBAM 2026, please reach out to the conference organising team directly. You can contact the APBAM team via submitting an online enquiry via the contact section of this page. We will respond promptly to discuss your goals, confirm available packages, and provide a formal sponsorship agreement.
The CCTS-A is a professional certification for clinicians trained to understand and treat addiction and traumatic stress as linked outcomes of nervous system dysregulation. Developed by Dr Robert Rhoton of the Arizona Trauma Institute, it applies a Salutogenic (wellness focused), nervous-system informed lens to case conceptualisation and trauma-addiction treatment planning. It is a specialised companion to the broader CCTS-I (individual trauma) certification.
Salutogenesis is a health framework developed by sociologist Aaron Antonovsky that focuses on factors which support human health and wellbeing, rather than on factors that cause disease. In the context of addiction treatment, a Salutogenic approach asks “What supports this person’s recovery?” rather than “What is wrong with them?” The training teaches clinicians to identify Generalised Resistance Resources (GRRs) and build a client’s sense of coherence -comprehensibility, manageability, and meaningfulness – as the foundation for lasting recovery.
The CCTS-A is open to qualified clinicians and mental health helpers working with individuals affected by addiction and/or trauma. This includes psychologists, counsellors, psychiatrists, physicians, social workers, addiction specialists, case managers, community health workers, peer support workers, and programme leaders. No prior trauma training certification is required, though a background in a helping profession is expected.
The CCTS-A training takes place over three full days from 31 August to 2 September 2026 at One Farrer Hotel, Singapore. It is the official pre-conference training for the Asia Pacific Behavioural & Addictions Medicine Conference (APBAM) 2026, which follows on 3–4 September 2026 at the same venue.
The CCTS-A training delivers 18 instructional hours across three days (6 hours per day). These hours qualify for Continuing Professional Development (CPD) credit. The APBAM 2026 Conference (3–4 September 2026) additionally qualifies for 2 days of Continuing Medical Education (CME). Delegates attending both the training and the conference bundle can accumulate the full credit.
The NeuroAffective Coherence (NAC) structure is a proprietary clinical framework developed by Dr. Robert Rhoton. It serves as a universal guide to enhancing the efficacy of any mental health modality by integrating nervous-system science, polyvagal theory, and salutogenic principles. The NAC does not replace existing therapeutic approaches; instead, it provides a coherent treatment architecture – across Preparation, Regulation, Integration, and Post-traumatic Growth stages – within which EMDR, CPT, SE, EFT, and other evidence-based treatments can be matched to client readiness and nervous-system state.
The CCTS-A training fee is SGD 1,200 (subject to prevailing government taxes). This includes all 18 hours of instruction, course materials, and the CCTS-A certification upon successful completion. A bundle option combining the CCTS-A training with full APBAM 2026 conference access is available for SGD 1,600 – a saving compared to purchasing both separately.
The CCTS-I (Certified Clinical Trauma Specialist – Individual) focuses on trauma treatment with individual clients using the NeuroAffective Coherence structure, without a specific addiction focus. The CCTS-A applies the same nervous-system and salutogenic principles with a dedicated specialisation in addiction — covering ACEs, dopamine and reward learning, harm reduction, motivational approaches for early recovery clients, and integration with MAT/MOUD and peer support systems. EMCC Singapore has previously offered the CCTS-I training; the APBAM 2026 CCTS-A is a new specialisation.
Yes. Day 2 of the training is substantially dedicated to harm reduction foundations and Integrative Harm Reduction Psychotherapy principles. Participants will learn to position harm reduction as a spectrum – from safer use through managed use to abstinence – and practice person-centred, polyvagal-informed language. The training addresses abstinence-only versus harm reduction debates by teaching a clinically integrative stance that preserves client safety, dignity, and individualised goals while maintaining clear ethical standards.
The CCTS-A certification is issued by the Arizona Trauma Institute, a globally recognised institution in trauma-informed care. The training is presented under the APBAM 2026 framework and is eligible for CPD credit. Clinicians are encouraged to verify specific recognition requirements with their professional licensing bodies in their jurisdiction, as recognition criteria differ across associations and countries in the Asia Pacific region.
Yes. The CCTS-A training is available as a standalone registration at SGD 1,200. Alternatively, you may register for the APBAM conference only (SGD 900) or take advantage of the bundle rate (CCTS-A + APBAM for SGD 1,600). If you are already committed to attending APBAM, the bundle offers significant added value for a minimal additional investment.
Abstract submissions for APBAM 2026 open on 1 April 2026 and close on 30 June 2026. We strongly recommend submitting at least one week before the deadline to allow time for any technical issues. Early submissions are encouraged and receive the same consideration as those submitted closer to the deadline.
Yes, multiple submissions from a single author are welcome. Each abstract must be submitted separately through the online portal, with its own title, track selection, and authorship information. If all are accepted, each presenting author must be a registered conference participant.
Yes. A copy of your submission will be sent automatically to the email address you provide in the form. If you do not receive a confirmation within 24 hours, please check your junk or spam folder, and then contact the organising committee at [email protected] for assistance.
Abstracts must not exceed 300 words. This limit applies to the abstract body only and does not include the title, keywords, or author information. Abstracts that exceed 300 words may be returned for revision before the review process can commence.
Abstracts should be structured to clearly communicate the following (where applicable to your work type):
You must also provide 3–5 keywords relevant to your submission.
Yes. All submissions and presentations at APBAM 2026 must be in English. This ensures accessibility across the diverse, multilingual Asia Pacific delegate community. Abstracts submitted in other languages will not be reviewed.
Oral Presentations are 20–30 minute presentations delivered to the conference audience, covering research findings, innovative clinical programmes, or theoretical models. They typically include a Q&A period.
Poster Presentations are visual displays of research or clinical projects; presenters are available at their poster for discussion with delegates. Both formats offer excellent visibility and networking opportunities.
Yes, you may indicate your preferred format (Oral or Poster) during submission. The Organising Committee reserves the right to recommend an alternative format based on the programme schedule and reviewer feedback. All decisions are made in the interest of creating the strongest possible scientific programme.
The reviewing committee aims to notify authors within one month of submission, with all notifications sent no later than 15 July 2026. Notifications will be sent to the email address of the presenting author, who is responsible for informing all co-authors of the outcome. If you have not received notification by 15 July 2026, please contact [email protected].
Abstracts are reviewed against the overall conference theme of “Emerging Trends in Addictions and Mental Health” and the specific track criteria. Reviewers assess relevance to the Asia Pacific context, quality of evidence or argumentation, clarity and structure, originality, and practical or policy implications. All submissions are reviewed by the APBAM 2026 Scientific Committee.
Yes. All accepted presenters must register as conference participants by the Presenter Registration Deadline of 30 August 2026. Abstracts from presenters who have not registered by this date may be withdrawn from the official APBAM 2026 programme. Registration details will be provided at the time of acceptance notification.
Yes. By submitting your abstract and accepting the acknowledgement terms, you agree that your poster and relevant presentation materials may be uploaded and published on the APBAM 2026 official website and social media platforms following the conference. This extends the reach of your work beyond the conference day to the broader Asia Pacific professional community.
Yes. The person completing the submission form is identified as the presenting author, who does not have to be the lead/first author. You must indicate in the form whether you are the lead author. If not, provide the lead author’s details separately. The presenting author is responsible for notifying all co-authors of the abstract’s status and must be a registered conference participant if accepted.
For all enquiries regarding abstract submission, please contact the APBAM 2026 Organising Committee: June Fong, Principal Psychologist, at [email protected]. We aim to respond to all enquiries within 2–3 business days.
APBAM — the Asia Pacific Behavioural & Addictions Medicine Conference – is the region’s premier multi-disciplinary conference dedicated to advancing knowledge and practice in addiction medicine and mental health. APBAM 2026 welcomes clinicians (psychiatrists, psychologists, counsellors, social workers), academic researchers, policymakers, public health professionals, and healthcare educators from across the Asia Pacific and internationally.